Literature DB >> 15572214

Mutating factor VIII: lessons from structure to function.

Philip J Fay1, P Vincent Jenkins.   

Abstract

Factor VIII, a metal ion-dependent heterodimer, circulates in complex with von Willebrand factor. At sites of vessel wall damage, this procofactor is activated to factor VIIIa by limited proteolysis and assembles onto an anionic phospholipid surface in complex with factor IXa to form the intrinsic factor Xase; an enzyme complex that efficiently converts factor X to factor Xa during the propagation phase of coagulation. Factor Xase activity is down-regulated by mechanisms that include self-dampening by dissociation of a critical factor VIIIa subunit and proteolytic inactivation by the activated protein C pathway. Recent studies identify putative metal ion coordination sites as well as ligands involved in the catabolism of the activated and procofactor forms of the protein. Our knowledge of these multiple intra- and inter-molecular interactions has been facilitated by the application of naturally occurring and site-directed mutations to study factor VIII structure and function. In this review, we document important and novel contributions following this line of investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15572214     DOI: 10.1016/j.blre.2004.02.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  12 in total

1.  Study on the efficacy and safety of Xueyou Mixture in treating hemophilia.

Authors:  Shan-xi Liu; Lin Jiang; Yi-guo Liu; Yue-qin He; Xin Liang; Wei-wei Kong; Jing Chen
Journal:  Chin J Integr Med       Date:  2007-06       Impact factor: 1.978

Review 2.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

Authors:  Anna P Lillis; Lauren B Van Duyn; Joanne E Murphy-Ullrich; Dudley K Strickland
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

3.  Identification of residues in the 558-loop of factor VIIIa A2 subunit that interact with factor IXa.

Authors:  Indu Jagannathan; H Travis Ichikawa; Tricia Kruger; Philip J Fay
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

4.  Enhancing factor VIII and VIIIa stability by combining mutations at the A2 domain interface and A1-C2 domain interface.

Authors:  H Wakabayashi; A E Griffiths; P J Fay
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824

5.  Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models.

Authors:  Lilley Leong; Derek Sim; Chandra Patel; Katherine Tran; Perry Liu; Elena Ho; Thomas Thompson; Peter J Kretschmer; Hironao Wakabayashi; Philip J Fay; John E Murphy
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

6.  Sequences flanking Arg336 in factor VIIIa modulate factor Xa-catalyzed cleavage rates at this site and cofactor function.

Authors:  Jennifer P DeAngelis; Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2012-03-12       Impact factor: 5.157

7.  Factor VIIIa A2 subunit shows a high affinity interaction with factor IXa: contribution of A2 subunit residues 707-714 to the interaction with factor IXa.

Authors:  Amy E Griffiths; Ivan Rydkin; Philip J Fay
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

8.  Domain organization of membrane-bound factor VIII.

Authors:  Svetla Stoilova-McPhie; Gillian C Lynch; Steven Ludtke; B Montgomery Pettitt
Journal:  Biopolymers       Date:  2013-07       Impact factor: 2.505

Review 9.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

Review 10.  Factor VIII structure and function.

Authors:  Philip J Fay
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.